Pharma

From May 1, Pay More For Second Jab Of Covishield

From May 1, Pay More For Second Jab Of Covishield

Reported by Animesh Singh | Wednesday April 21, 2021

COVID-19 vaccine: From May 1, 2021, a jab of Serum Institute of India's Covishield vaccine will cost Rs 600 in private hospitals.

India's New Unicorn Is EPharmacy

India's New Unicorn Is EPharmacy

Saritha Rai, Bloomberg | Wednesday April 07, 2021

API Holdings Pvt said it will use funds to expand its network and add more tele-consultations to link up customers with the 60,000 brick-and-mortar pharmacies and 4,000 doctors it already has on its books.

Cadila Seeks Nod To Repurpose Hepatitis C Drug For COVID-19 In India

Cadila Seeks Nod To Repurpose Hepatitis C Drug For COVID-19 In India

Reuters | Monday April 05, 2021

A single dose of the Hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said.

Indian Pharma Firms Go Local Seeking To End Reliance On China

Indian Pharma Firms Go Local Seeking To End Reliance On China

Reuters | Tuesday February 23, 2021

Indian Pharma Firms: Although India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounted for half of its API needs in 2019 from nearly nothing three decades ago

Dr Reddy's Starts Process For Emergency Use Authorisation Of Covid-19 Vaccine Sputnik V

Dr Reddy's Starts Process For Emergency Use Authorisation Of Covid-19 Vaccine Sputnik V

Edited by Nirmalya Sen | Friday February 19, 2021

Dr Reddy's will present the safety profile of phase two study and interim data of phase three study which is expected to completed by February 21

AstraZeneca Shares Up 4% On WHO's Emergency Use Approval Of Covid-19 Vaccine

AstraZeneca Shares Up 4% On WHO's Emergency Use Approval Of Covid-19 Vaccine

Edited by Nirmalya Sen | Tuesday February 16, 2021

WHO's move widens access to the relatively inexpensive shot in the developing world

Dr. Reddy's Laboratories Q3 Profit At Rs 20 Crore

Dr. Reddy's Laboratories Q3 Profit At Rs 20 Crore

Edited by Nirmalya Sen | Friday January 29, 2021

Revenue for the third quarter came at Rs 4,930 crore, which was up 12 per cent year-over-year and 1 per cent quarter-over-quarter

Sun Pharma Q3 Profit Doubles To Rs 1,852.5 Crore

Sun Pharma Q3 Profit Doubles To Rs 1,852.5 Crore

Edited by Nirmalya Sen | Friday January 29, 2021

The pharma major reported a net profit of Rs 1,852.5 crore in Q3FY21

Novavax Claims Covid-19 Vaccine 89% Effective In UK Trial, Less In South Africa, Shares Jump

Novavax Claims Covid-19 Vaccine 89% Effective In UK Trial, Less In South Africa, Shares Jump

Edited by Nirmalya Sen | Friday January 29, 2021

Serum Institute Of India has applied to conduct local trial for Novavax vaccine

Dr. Reddy's Ends Review Of Covid-19 Drug Avigan In Kuwait

Dr. Reddy's Ends Review Of Covid-19 Drug Avigan In Kuwait

Edited by Nirmalya Sen | Wednesday January 27, 2021

Fujifilm, Dr. Reddy's and GRA had entered into a deal in July to sell Avigan globally excluding Japan, China and Russia

Moderna Believes Vaccine Will Work Against New Variants

Moderna Believes Vaccine Will Work Against New Variants

Edited by Nirmalya Sen | Tuesday January 26, 2021

Moderna Covid-19 Vaccine: The emergence of new variants in Britain, South Africa and Brazil has created some concern that mutations in the virus may make vaccines less effective

Will Receive Two Million AstraZeneca Doses By Friday From India: Brazil

Will Receive Two Million AstraZeneca Doses By Friday From India: Brazil

Edited by Nirmalya Sen | Friday January 22, 2021

The announcement comes amid delays in receiving the vaccine from India, the latest in a series of miscues surrounding the country's inoculations drive

India Will Start Commercial Vaccine Exports With Shipments to Morocco, Brazil

India Will Start Commercial Vaccine Exports With Shipments to Morocco, Brazil

Edited by Nirmalya Sen | Friday January 22, 2021

Serum Institute of India will also send the Covid-19 vaccine to South Africa and Saudi Arabia

South Africa To Pay $5.25 Per Dose For AstraZeneca Vaccine From India's SII

South Africa To Pay $5.25 Per Dose For AstraZeneca Vaccine From India's SII

Edited by Nirmalya Sen | Thursday January 21, 2021

South Africa is hosting clinical trials of the vaccine developed by AstraZeneca in partnership with Oxford University, raising questions about the higher price it will be paying

Serum Institute Awaits WHO Emergency Approval For AstraZeneca Shot Soon

Serum Institute Awaits WHO Emergency Approval For AstraZeneca Shot Soon

Edited by Nirmalya Sen | Thursday January 14, 2021

The World Health Organization (WHO) listed Pfizer and BioNTech's Covid-19 shot for emergency use on December 31 as it sought to accelerate vaccination in the developing world, which is badly lagging Western countries

1234...5